tetano
Editor, Senior Moderator
Front Pediatr
. 2022 Mar 4;10:827466.
doi: 10.3389/fped.2022.827466. eCollection 2022.
Case Report: Clinical and Pathological Findings of a Recurrent C3 Glomerulopathy With Superimposed Membranoproliferative Glomerulonephritis Pattern and Cryoglobulinemia Associated With COVID-19
Nastaran Daneshgar[SUP] 1 [/SUP], Peir-In Liang[SUP] 1 2 [/SUP], Christina J Michels[SUP] 3 [/SUP], Carla M Nester[SUP] 3 4 [/SUP], Lyndsay A Harshman[SUP] 3 [/SUP], Dao-Fu Dai[SUP] 1 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) may cause a wide spectrum of kidney pathologies. The impact of COVID-19 is unclear in the context of the complement system abnormalities, including C3 glomerulopathy (C3G). In this report, we describe a young adult receiving a kidney transplant for C3 glomerulopathy (C3G), a disorder of the alternative complement pathway. The patient developed a recurrent C3G ~7 months after transplantation. His post-transplant course was complicated by SARS-CoV-2 infection. There was a progression of glomerulonephritis, characterized by de novo immune-complex mediated membranoproliferative glomerulonephritis pattern of injury with crescentic and necrotizing features, along with positive immunoglobulins, persistent IgM staining and the presence of cryoglobulinemia. COVID-19 may have aggravated the inherent complement dysregulation and contributed to cryoglobulinemia observed in this patient. Our study of 5 sequential kidney allograft biopsy series implicates that COVID-19 in this patient promoted a superimposed immune complex-mediated glomerulonephritis with membranoproliferative glomerulonephritis (MPGN) pattern and cryoglobulinemia, which was a potentiating factor in allograft loss. This work represents the first report of cryoglobulinemic GN after COVID-19.
Keywords: C3 glomerulopathy (C3G); COVID-19; case report; cryoglobulinemia; glomerulonephropathy; kidney transplant; membranoproliferative glomerulonephritis (MPGN).
. 2022 Mar 4;10:827466.
doi: 10.3389/fped.2022.827466. eCollection 2022.
Case Report: Clinical and Pathological Findings of a Recurrent C3 Glomerulopathy With Superimposed Membranoproliferative Glomerulonephritis Pattern and Cryoglobulinemia Associated With COVID-19
Nastaran Daneshgar[SUP] 1 [/SUP], Peir-In Liang[SUP] 1 2 [/SUP], Christina J Michels[SUP] 3 [/SUP], Carla M Nester[SUP] 3 4 [/SUP], Lyndsay A Harshman[SUP] 3 [/SUP], Dao-Fu Dai[SUP] 1 [/SUP]
Affiliations
- PMID: 35311055
- PMCID: PMC8931284
- DOI: 10.3389/fped.2022.827466
Abstract
Coronavirus disease 2019 (COVID-19) may cause a wide spectrum of kidney pathologies. The impact of COVID-19 is unclear in the context of the complement system abnormalities, including C3 glomerulopathy (C3G). In this report, we describe a young adult receiving a kidney transplant for C3 glomerulopathy (C3G), a disorder of the alternative complement pathway. The patient developed a recurrent C3G ~7 months after transplantation. His post-transplant course was complicated by SARS-CoV-2 infection. There was a progression of glomerulonephritis, characterized by de novo immune-complex mediated membranoproliferative glomerulonephritis pattern of injury with crescentic and necrotizing features, along with positive immunoglobulins, persistent IgM staining and the presence of cryoglobulinemia. COVID-19 may have aggravated the inherent complement dysregulation and contributed to cryoglobulinemia observed in this patient. Our study of 5 sequential kidney allograft biopsy series implicates that COVID-19 in this patient promoted a superimposed immune complex-mediated glomerulonephritis with membranoproliferative glomerulonephritis (MPGN) pattern and cryoglobulinemia, which was a potentiating factor in allograft loss. This work represents the first report of cryoglobulinemic GN after COVID-19.
Keywords: C3 glomerulopathy (C3G); COVID-19; case report; cryoglobulinemia; glomerulonephropathy; kidney transplant; membranoproliferative glomerulonephritis (MPGN).